Therapix Biosciences Competitors and Similar CompaniesClear all

Therapix Biosciences's competitors and similar companies include Verdemed, Medipure Pharmaceuticals, Revive Therapeutics and Bedrocan.

	Therapix Biosciences Therapix Biosciences (formerly NasVax) is a specialty clinical-stage company that focuses on cannabinoid pharmaceuticals.	Verdemed Verdemed is a pharmaceutical cannabis company.	Medipure Pharmaceuticals Medipure Pharmaceuticals is a company that focuses on discovering and developing proprietary endocannabinoid system-based prescription drugs.	Revive Therapeutics Revive Therapeutics is a life sciences company focused on the research and development of therapeutics for rare disorders and infectious diseases.	Bedrocan Bedrocan is a company that specializes in the production of standardized medicinal-grade cannabis.
Founding Date	Founding Date 2004	Founding Date 2018	Founding Date 2014	Founding Date 2012	Founding Date 1984
Type	Type Public	Type Private	Type Private	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech cannabis drug development mental health pharma	Tags Healthcare biotech cannabis drug development pharma	Tags Healthcare biotech cannabis drug development pharma	Tags Healthcare biotech cannabis drug development pharma	Tags Healthcare biotech cannabis drug development pharma
Locations	Locations Giv'atayim, IL HQ	Locations Toronto, CA HQ	Locations North Vancouver, CA HQ Burnaby, CA	Locations Toronto, CA HQ	Locations Veendam, NL HQ
Employees	Employees 11	Employees 10	Employees 525% increase	Employees N/A	Employees 791% decrease
Valuation ($)	Valuation ($) 4.5 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 2.6 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $856k (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $225k (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $631k (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit N/A
Net income	Net income ($12.6m) (FY, 2025)	Net income N/A	Net income N/A	Net income ($11m) (FY, 2025)	Net income N/A